Outset Medical Receivables

Outset Medical (OM) currently reports a receivables of $29M as of June 2026. That compares with $35M in the prior-year period — down 16.2% year over year. Use the charts on this page to explore Outset Medical's receivables history and peer comparisons.

Outset Medical's receivables decreased from $35M to $29M — a 16.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Outset Medical reported $29M in receivables as of June 2026. That compares with $35M in the prior-year period — down 16.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Outset Medical, and consider following OM for alerts when major investors trade the stock.

Outset Medical is classified in the Technology sector. On receivables, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing OM with unrelated industries.